SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo (Q28201653)

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Regulation of activity of the transcription factor GATA-1 by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Analysis of chromatin-immunopurified MeCP2-associated fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Cell cycle-dependent recruitment of HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F target promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

PAS is a dimerization domain common to Drosophila period and several transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

CREB-Binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Acetylation of general transcription factors by histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Regulation of E2F1 activity by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

AML1 gene over-expression in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Point mutations of the RUNx1/AML1 gene in sporadic and familial myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G(1) is controlled by a deacetylase- and E2F-associated bipartite repressor element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Regulation of chromatin structure by site-specific histone H3 methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Core-binding factors in haematopoiesis and leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Histone acetylation and the cell-cycle in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Self-interaction of heterochromatin protein 1 is required for direct binding to histone methyltransferase, SUV39H1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

Acetylation of adenovirus E1A regulates binding of the transcriptional corepressor CtBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

The core binding factor (CBF) alpha interaction domain and the smooth muscle myosin heavy chain (SMMHC) segment of CBFbeta-SMMHC are both required to slow cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

inferred from DOI database lookup

7 January 2021

based on heuristic

E2F Family Members Are Differentially Regulated by Reversible Acetylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600

inferred from DOI database lookup

7 January 2021

based on heuristic

Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206600